Download App

Log in to access Online Inquiry
Company Overview More
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
CEO: Hassanein M.D., Waleed H.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

TMDX TransMedics
28.010-0.390-1.37%
Post Mkt Price
28.01000.00%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
-39.04% 72M -26.42% 92.45M -26.42% 92.45M -22.5% 102.86M
-Cash and cash equivalents
-33.04% 17.9M 4.06% 25.58M 4.06% 25.58M 5.13% 22.5M
-Short-term investments
-40.8% 54.1M -33.83% 66.87M -33.83% 66.87M -27.81% 80.36M
Receivables
58.54% 11.72M -13.55% 5.93M -13.55% 5.93M -32.42% 4.15M
-Accounts receivable
58.54% 11.72M -13.55% 5.93M -13.55% 5.93M -32.42% 4.15M
Inventory
41.4% 16.71M 24.51% 14.86M 24.51% 14.86M 14.52% 14.87M
Prepaid assets
66.59% 5.36M 134.74% 5.46M 134.74% 5.46M 61.92% 3.7M
Total current assets
-24.72% 105.8M -19.12% 118.71M -19.12% 118.71M -18.52% 125.58M
Non current assets
Net PPE
274.17% 17.71M 230% 15.69M 230% 15.69M 7.95% 5.06M
-Gross PPE
-- 17.71M 98.91% 25.42M -- 15.69M -- --
-Accumulated depreciation
-- -- -21.28% -9.74M -- -- -- --
Other non current assets
-1.19% 500K -1.19% 500K -1.19% 500K 0% 506K
Total non current assets
247.58% 18.21M 207.76% 16.19M 207.76% 16.19M 7.18% 5.57M
Total assets
-14.94% 124.01M -11.27% 134.89M -11.27% 134.89M -17.68% 131.15M
Liabilities
Current liabilities
Payables
127.62% 2.93M 451.49% 6.65M 451.49% 6.65M 244.73% 2.68M
-accounts payable
127.62% 2.93M 451.49% 6.65M 451.49% 6.65M 244.73% 2.68M
Current accrued expenses
58.47% 15.74M 58.35% 16.34M 58.35% 16.34M 11.29% 12.77M
Current debt and capital lease obligation
-- 1.34M -- -- -- -- -- --
-Current capital lease obligation
-- 1.34M -- -- -- -- -- --
Current deferred liabilities
-54% 247K -29.78% 250K -29.78% 250K -65.6% 472K
Current liabilities
72.29% 20.26M 95.62% 23.24M 95.62% 23.24M 16.87% 15.92M
Non current liabilities
Long term debt and capital lease obligation
26.03% 43.84M 26.38% 43.8M -75.17% 8.6M 1.54% 35.06M
-Long term debt
1.57% 35.33M 1.56% 35.2M -- -- 1.54% 35.06M
-Long term capital lease obligation
-- 8.51M -- 8.6M -- 8.6M -- --
Non current deferred liabilities
-- -- -- 0 -- -- -0.43% 1.62M
Derivative product liabilities
-- -- -- -- -- 35.2M -- --
Total non current liabilities
20.61% 43.84M 20.81% 43.8M 20.81% 43.8M 1.46% 36.67M
Total liabilities
33.24% 64.1M 39.27% 67.04M 39.27% 67.04M 5.68% 52.6M
Shareholders'equity
Share capital
1.84% 513.2M 1.65% 510.49M -- -- 1.39% 508.46M
-common stock
1.84% 513.2M 1.65% 510.49M -- -- 1.39% 508.46M
-Preferred stock
-- 0 -- 0 -- -- -- 0
Retained earnings
-11.54% -453.01M -11.1% -442.45M -- -- -9.66% -429.78M
Gains losses not affecting retained earnings
-220.22% -285K -97.89% -188K -- -- -718.75% -131K
Total stockholders'equity
-38.66% 59.91M -34.69% 67.85M -34.69% 67.85M -28.3% 78.55M
Total equity
-38.66% 59.91M -34.69% 67.85M -34.69% 67.85M -28.3% 78.55M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion with Explanation----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%